SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies informs about analyst meet

01 Dec 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that Anand Velumani, Director of the wholly owned subsidiary, Nueclear Healthcare, and Aditya Shinde, Deputy General Manager- Finance would be participating at B & Ks Investor Conference- Emergent India- 2018 organized by Batlivala & Karani Securities India, at Hotel Trident BKC, Mumbai, on Wednesday, 5th December 2018, where the representatives of various Funds would be meeting, from 10.00 A.M to 6.00 P.M.

The above information is a part of company’s filings submitted to BSE.

 

 

Thyrocare Tech. Share Price

400.55 -3.50 (-0.87%)
30-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×